AIE regimen
A regimen consisting of cytarabine (Ara-C), idarubicin and etoposide, used as an induction treatment for pediatric acute myeloid leukemia (AML). High-dose cytarabine/etoposide/idarubicin regimen may be used for the treatment of AML.
| Synonym: | AraC-idarubicin-etoposide regimen cytarabine-idarubicin-etoposide regimen MRC AML10 study-AIE regimen |
|---|---|
| Abbreviation: | AIE ICE |